Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Dunn

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Leukemia|May 31, 2017
PPAR-delta modulates membrane cholesterol and cytokine signaling in malignant B cellsL Sun, Y Shi, G Wang, et al.
Oncogene|January 18, 2012
MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibitionA Astanehe, M R Finkbeiner, M Krzywinski, et al.
Oncogene|July 16, 2013
Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancerN Panupinthu, S Yu, D Zhang, et al.
Oncogene|March 23, 2011
YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplificationA H Davies, I Barrett, M R Pambid, et al.
Australian Veterinary Journal|October 20, 2011
The first identified case of pandemic H1N1 influenza in pigs in AustraliaP K Holyoake, P D Kirkland, R J Davis, et al.
Oncogene|May 12, 2009
The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1A Astanehe, M R Finkbeiner, P Hojabrpour, et al.
Neoplasia (New York, N.Y.)|May 4, 2002
Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cellsJ S Oh, J E Kucab, P R Bushel, et al.
Pharmaceutical Research|December 1, 1994
Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymersS Stolnik, S E Dunn, M C Garnett, et al.
Antimicrobial Agents and Chemotherapy|October 23, 1997
In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucksJ M Cullen, S L Smith, M G Davis, et al.
Bone Marrow Transplantation|March 2, 2010
Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031G D E Cuvelier, A Kariminia, H Fujii, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Leukemia|May 31, 2017
PPAR-delta modulates membrane cholesterol and cytokine signaling in malignant B cellsL Sun, Y Shi, G Wang, et al.
Oncogene|January 18, 2012
MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibitionA Astanehe, M R Finkbeiner, M Krzywinski, et al.
Oncogene|July 16, 2013
Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancerN Panupinthu, S Yu, D Zhang, et al.
Oncogene|March 23, 2011
YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplificationA H Davies, I Barrett, M R Pambid, et al.
Australian Veterinary Journal|October 20, 2011
The first identified case of pandemic H1N1 influenza in pigs in AustraliaP K Holyoake, P D Kirkland, R J Davis, et al.
Oncogene|May 12, 2009
The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1A Astanehe, M R Finkbeiner, P Hojabrpour, et al.
Neoplasia (New York, N.Y.)|May 4, 2002
Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cellsJ S Oh, J E Kucab, P R Bushel, et al.
Pharmaceutical Research|December 1, 1994
Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymersS Stolnik, S E Dunn, M C Garnett, et al.
Antimicrobial Agents and Chemotherapy|October 23, 1997
In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucksJ M Cullen, S L Smith, M G Davis, et al.
Bone Marrow Transplantation|March 2, 2010
Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031G D E Cuvelier, A Kariminia, H Fujii, et al.
Pageof 5